- Home
- GFAI vs ENLV Comparison
GFAI vs ENLV Comparison
Compare GFAI & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFAI
- ENLV
- Stock Information
- Founded
- GFAI 2018
- ENLV 2005
- Country
- GFAI Singapore
- ENLV Israel
- Employees
- GFAI N/A
- ENLV N/A
- Industry
- GFAI Diversified Commercial Services
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- GFAI Consumer Discretionary
- ENLV Health Care
- Exchange
- GFAI Nasdaq
- ENLV Nasdaq
- Market Cap
- GFAI 20.7M
- ENLV 23.7M
- IPO Year
- GFAI N/A
- ENLV 1995
- Fundamental
- Price
- GFAI $1.03
- ENLV $1.02
- Analyst Decision
- GFAI Strong Buy
- ENLV Strong Buy
- Analyst Count
- GFAI 2
- ENLV 2
- Target Price
- GFAI $6.75
- ENLV $10.00
- AVG Volume (30 Days)
- GFAI 370.3K
- ENLV 254.1K
- Earning Date
- GFAI 04-28-2025
- ENLV 04-04-2025
- Dividend Yield
- GFAI N/A
- ENLV N/A
- EPS Growth
- GFAI N/A
- ENLV N/A
- EPS
- GFAI N/A
- ENLV N/A
- Revenue
- GFAI $35,841,743.00
- ENLV N/A
- Revenue This Year
- GFAI $0.37
- ENLV N/A
- Revenue Next Year
- GFAI $5.60
- ENLV N/A
- P/E Ratio
- GFAI N/A
- ENLV N/A
- Revenue Growth
- GFAI 1.78
- ENLV N/A
- 52 Week Low
- GFAI $0.94
- ENLV $0.81
- 52 Week High
- GFAI $4.20
- ENLV $4.59
- Technical
- Relative Strength Index (RSI)
- GFAI 39.69
- ENLV 43.74
- Support Level
- GFAI $1.08
- ENLV $1.01
- Resistance Level
- GFAI $1.25
- ENLV $1.13
- Average True Range (ATR)
- GFAI 0.07
- ENLV 0.10
- MACD
- GFAI 0.02
- ENLV -0.01
- Stochastic Oscillator
- GFAI 20.86
- ENLV 6.90
About GFAI Guardforce AI Co. Limited
Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.